APA (7th ed.) Citation

D, G., M, N., SZ, W., CE, Z., YF, Z., ZW, Y., . . . XH, X. (2020). Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection. Frontiers in pharmacology, 11, 746. https://doi.org/10.3389/fphar.2020.00746

Chicago Style (17th ed.) Citation

D, Gao, et al. "Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection." Frontiers in Pharmacology 11 (2020): 746. https://doi.org/10.3389/fphar.2020.00746.

MLA (9th ed.) Citation

D, Gao, et al. "Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection." Frontiers in Pharmacology, vol. 11, 2020, p. 746, https://doi.org/10.3389/fphar.2020.00746.